In this interview, Dr. Neil Sheppard, director of the Therapeutic Innovation in Natural Killer cells (THINK) lab at the ...

Findings indicate blood group A elevates the risk of primary biliary cholangitis, suggesting ABO group analysis could aid in ...

Conventional T cells epigenetically reprogrammed into stable, antigen-specific regulatory T cells achieved long-lasting immune regulation in models of inflammatory bowel disease and graft-versus-host ...

The main market opportunities lie in developing CD40-targeting therapies, including agonists for cancer immunotherapy and antagonists for autoimmune diseases. Innovations focus on overcoming systemic ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

HHS Secretary Robert F. Kennedy Jr. claims that the aluminum ingredients in vaccines cause a variety of harmful reactions, ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

Jefferies London Healthcare Conference 2025 November 17, 2025 10:00 AM ESTCompany ParticipantsLawrence Blatt - ...

According to Mordor Intelligence, the cell therapy market is valued at USD 5.5 billion in 2025 and is projected to surpass USD 12.2 billion by 2030, advancing at an 17.05% CAGR, driven by rising ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...

"Grey's Anatomy" star James Pickens Jr. revealed his prostate cancer diagnosis, sharing a public service announcement on the ...